Martina Sanlorenzo

Pembrolizumab Cutaneous Adverse Events and Their Association With Disease Progression

Martina Sanlorenzo, Igor Vujic, Adil Daud et al. · JAMA Dermatology · 2015 · 445 citations · Full text

Global patterns of care in advanced stage mycosis fungoides/Sezary syndrome: a multicenter retrospective follow-up study from the Cutaneous Lymphoma International Consortium

Pietro Quaglino, Milena Maule, H. Miles Prince et al. · Annals of Oncology · 2017 · 134 citations · Full text

Lymphoid Neoplasia, Immunodeficiencies, Global Patterns +6

Sentinel Lymph Node Biopsy in Thick-Melanoma Patients (N=350): What is Its Prognostic Role?

Simone Ribero, Simona Osella‐Abate, Martina Sanlorenzo et al. · Annals of Surgical Oncology · 2014 · 79 citations · Full text

Thick-melanoma Patients, Surgical Oncology, Skin Cancer +11

DNA and aptamer stabilized gold nanoparticles for targeted delivery of anticancer therapeutics

Alfonso Latorre, Christian Posch, Yolanda Garcimartín et al. · Nanoscale · 2014 · 77 citations

Nanoparticles, Nanotherapeutics, Engineering +16

Comparative profile of cutaneous adverse events: BRAF/MEK inhibitor combination therapy versus BRAF monotherapy in melanoma

Martina Sanlorenzo, Aditi Choudhry, Igor Vujic et al. · Journal of the American Academy of Dermatology · 2014 · 76 citations · Full text

Skin Cancer, Comparative Profile, Medicine +6